Advances in cardiovascular effects of tanshinone II(A).
- Author:
Fen-yan CHEN
;
Ren GUO
;
Bi-kui ZHANG
- Publication Type:Journal Article
- MeSH:
Animals;
Cardiovascular Diseases;
drug therapy;
genetics;
metabolism;
physiopathology;
Coronary Vessels;
drug effects;
physiopathology;
Diterpenes, Abietane;
therapeutic use;
Humans
- From:
China Journal of Chinese Materia Medica
2015;40(9):1649-1653
- CountryChina
- Language:Chinese
-
Abstract:
Cardiovascular diseases, like coronary heart disease and myocardial infarction, are the most common cause of death worldwide. Chinese medicines have demonstrated rich cardioprotective activities for clinical applications. Salvia miltiorrhiza, a very important component of traditional Chinese medicine, can promote blood circulation and relieve blood stasis. Salvia miltiorrhiza is widely used in treatment of cardiovascular and cerebrovascular disease such as coronary heart disease and cerebral infarction ( CI). Tanshinone II(A), the major lipophilic components extracted from the root of S. miltiorrhiza, possesses anti-atherosclerosis, anti-cardiac hypertrophy, anti-oxidant, anti-arrhythmia and so on. This paper discusses current research status of tanshinone II(A) in cardioprotective effects.
